Showing results (1-10 of 70) with videos related to
Sort By:
Pageof 7
CNS & Neurological Disorders Drug Targets|January 9, 2009
Selective antagonism at dopamine D3 receptors as a target for drug addiction pharmacotherapy: a review of preclinical evidenceChristian HeidbrederEuropean Journal of Pharmacology|October 29, 2005
Novel pharmacotherapeutic targets for the management of drug addictionChristian HeidbrederCurrent Topics in Behavioral Neurosciences|January 13, 2011
Advances in animal models of drug addictionChristian HeidbrederNaunyn-Schmiedeberg'S Archives of Pharmacology|October 30, 2012
Rationale in support of the use of selective dopamine D₃ receptor antagonists for the pharmacotherapeutic management of substance use disordersChristian HeidbrederRecent Patents on CNS Drug Discovery|January 29, 2008
Selective dopamine D3 receptor antagonists: a review 2001-2005Fabrizio Micheli, Christian HeidbrederExpert Opinion on Therapeutic Patents|January 4, 2013
Dopamine D3 receptor antagonists: a patent review (2007 - 2012)Fabrizio Micheli, Christian HeidbrederSynapse (New York, N.Y.)|May 30, 2003
Cytoskeletal changes in the hippocampus following restraint stress: role of serotonin and microtubulesMassimiliano Bianchi, Christian Heidbreder, Francesco CrespiCurrent Opinion in Pharmacology|February 26, 2014
Pharmacologically, are smokers the same as non-smokers?Massimo Bani, Anne Andorn, Christian HeidbrederDrug and Alcohol Dependence Reports|September 12, 2024
Synthetic opioids have disrupted conventional wisdom for treating opioid overdosePhil Skolnick, Jordan Paavola, Christian HeidbrederJournal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 27, 2002
Amino acid neurotransmitters: separation approaches and diagnostic valueAjit J Shah, Francesco Crespi, Christian HeidbrederPageof 7